[Diagnosis and therapy for patients with vascular parkinsonism].
D000405:Akinetic Mutism; D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000150:complications / Q000517:prevention & control; D015140:Dementia, Vascular; D003937:Diagnosis, Differential; D020233:Gait Disorders, Neurologic; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009127:Muscle Rigidity; D010302:Parkinson Disease, Secondary / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011187:Posture; D055502:Secondary Prevention; D014202:Tremor
D000978:Antiparkinson Agents; D010975:Platelet Aggregation Inhibitors; D007980:Levodopa; D000547:Amantadine